Avenue Therapeutics Inc

NASDAQ:ATXI  
1.59
-0.07 (-4.22%)
Products

Avenue Therapeutics Submitted Formal Dispute Resolution Request To FDA

Published: 09/01/2021 12:43 GMT
Avenue Therapeutics Inc (ATXI) - Avenue Therapeutics Inc - on August 31, Submitted Formal Dispute Resolution Request to FDA for Crl Issued by FDA to Related to Its Iv Tramadol NDA.
Avenue Therapeutics Inc - Submission of Fdrr Follows Appeal Denied Letter From Office of Neuroscience of FDA.